Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-09-28

Clinical Trial Update: Irinotecan/Oxaliplatin/5-Fluorouracil/Leucovorin/Cetuximab As First Line Treatment In Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating a first-line regimen of Irinotecan, Oxaliplatin, 5-Fluorouracil, Leucovorin, and Cetuximab for metastatic colorectal cancer has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Adrucil (5-fluorouracil)
  • Camptosar (irinotecan)
  • ERBITUX (cetuximab)
  • Eloxatin (oxaliplatin)
  • Wellcovorin (leucovorin calcium)

Snippet

Sponsor: University Hospital of Crete | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: COMPLETED